221 related articles for article (PubMed ID: 19747067)
1. Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer.
Gonzalez YM; Ghaly ES
Drug Dev Ind Pharm; 2010 Jan; 36(1):64-71. PubMed ID: 19747067
[TBL] [Abstract][Full Text] [Related]
2. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
[TBL] [Abstract][Full Text] [Related]
3. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
4. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
5. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
Jannin V; Pochard E; Chambin O
Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
[TBL] [Abstract][Full Text] [Related]
6. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
[TBL] [Abstract][Full Text] [Related]
7. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
[TBL] [Abstract][Full Text] [Related]
8. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
Escudero JJ; Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
[TBL] [Abstract][Full Text] [Related]
9. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
Chen L; Wang F
Pharmazie; 2013 Oct; 68(10):796-9. PubMed ID: 24273882
[TBL] [Abstract][Full Text] [Related]
10. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
11. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
Miranda A; Millán M; Caraballo I
Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
[TBL] [Abstract][Full Text] [Related]
13. Matrix tablets: the effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests.
Mamani PL; Ruiz-Caro R; Veiga MD
AAPS PharmSciTech; 2012 Dec; 13(4):1073-83. PubMed ID: 22907778
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release.
Al-Hanbali OA; Hamed R; Arafat M; Bakkour Y; Al-Matubsi H; Mansour R; Al-Bataineh Y; Aldhoun M; Sarfraz M; Dardas AKY
Pak J Pharm Sci; 2018 Jan; 31(1(Suppl.)):345-351. PubMed ID: 29386164
[TBL] [Abstract][Full Text] [Related]
15. The butterfly effect: a physical phenomenon of hypromellose matrices during dissolution and the factors affecting its occurrence.
Cahyadi C; Chan LW; Colombo P; Heng PW
Int J Pharm; 2011 Mar; 406(1-2):31-40. PubMed ID: 21187134
[TBL] [Abstract][Full Text] [Related]
16. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
Lee KR; Kim EJ; Seo SW; Choi HK
Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
[TBL] [Abstract][Full Text] [Related]
17. The influence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets.
Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2013 Aug; 39(8):1167-74. PubMed ID: 22540355
[TBL] [Abstract][Full Text] [Related]
18. Matrix polymeric excipients: comparing a novel interpolyelectrolyte complex with hydroxypropylmethylcellulose.
Lu Z; Chen W; Olivier E; Hamman JH
Drug Deliv; 2008 Feb; 15(2):87-96. PubMed ID: 18293194
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chlorpheniramine maleate release from hydrophilic swellable polymer systems.
Melendez M; Ghaly ES
P R Health Sci J; 1997 Sep; 16(3):259-63. PubMed ID: 9431564
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
Kadam VD; Gattani SG
Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
